Patents by Inventor Anita B. Roberts

Anita B. Roberts has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030139366
    Abstract: The invention is related to modulation of Smad3 expression to prevent fibrosis and improve wound healing. Aspects of the invention, for example, include approaches to improve wound healing and/or reduce or prevent fibrosis by inhibiting Smad3. Embodiments described herein also include approaches to identify componds that modulate Smad3 expression and the preparation of pharmaceuticals comprising said compounds.
    Type: Application
    Filed: November 18, 2002
    Publication date: July 24, 2003
    Inventors: Anita B. Roberts, Gillian S. Ashcroft, Angelo Russo, James B. Mitchell
  • Publication number: 20030124571
    Abstract: The invention provides a newly identified and isolated nucleotide sequence encoding a polypeptide referred to in the present application as ARTS, for Apoptosis Related protein in the TGF-&bgr; Signaling pathway.
    Type: Application
    Filed: July 29, 2002
    Publication date: July 3, 2003
    Applicant: The Government of the United States of America
    Inventors: Sarit Larisch, Seong-Jin Kim, Robert J. Lechleider, Anita B. Roberts, Youngsuk Yi
  • Patent number: 5705477
    Abstract: A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-.beta. which is activated by either a TGF-.alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.
    Type: Grant
    Filed: July 5, 1994
    Date of Patent: January 6, 1998
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael B. Sporn, Anita B. Roberts
  • Patent number: 5656587
    Abstract: A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-.beta. which is activated by either a TGF-.alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.
    Type: Grant
    Filed: April 16, 1993
    Date of Patent: August 12, 1997
    Assignee: The United States of America as represented by the Secretary of the Department of Health and Human Services
    Inventors: Michael B. Sporn, Anita B. Roberts
  • Patent number: 5104977
    Abstract: A composition for the promotion of cell proliferation and tissue repair in animals having as active ingredients a TGF-.beta. which is activated by either a TGF-.alpha. or an EGF or both; and methods for administration. As another embodiment these active ingredients can be admixed with other (secondary) growth factors.
    Type: Grant
    Filed: February 8, 1989
    Date of Patent: April 14, 1992
    Assignee: The United States of America as represented by the Department of Health and Human Services
    Inventors: Michael B. Sporn, Anita B. Roberts, Richard K. Assoian, Charles A. Frolik